Latest stories on ANVS
Annovis Bio Completes Enrollment in Pivotal Alzheimer’s Trial
TipRanks63 · neutralproduct/pr
Annovis Bio, Inc. (ANVS) files 8-K
SEC 8-K50 · neutralgeneral
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease | ANVS Stock News
StockTitan67 · bullishproduct/pr
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer | ANVS Stock News
StockTitan63 · neutralproduct/pr
Annovis Bio, Inc. (ANVS) files 8-K
SEC 8-K50 · neutralgeneral
Annovis Bio regains NYSE listing compliance
Seeking Alpha59 · neutralgeneral
Annovis Bio Regains NYSE Listing Compliance | ANVS Stock News
StockTitan55 · neutralgeneral
Annovis Bio Announces Dilutive Equity Offering for Trials
TipRanks28 · bearishgeneral
ANVS: [8-K] Annovis Bio, Inc. Reports Material Event
StockTitan SEC50 · neutralgeneral
ANVS: [424B5] Annovis Bio, Inc. Prospectus Supplement (Debt Securities)
StockTitan SEC50 · neutralgeneral
Annovis launches proposed public stock and warrant offering
Seeking Alpha24 · bearishgeneral
Annovis Bio GAAP EPS of -$0.63 misses by $0.23
Seeking Alpha34 · bearishearnings
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
Business Insider56 · neutralearnings